π Tender Overview
Scope :
In Kenya, infectious diseases such as HIV/AIDS, tuberculosis, and malaria are the top six health hazards, and sudden outbreaks of such diseases due to inadequate public health measures have been reported in recent years. The outbreak of the novel coronavirus disease (COVID-19) has not only strained the medical system, but also had a serious impact on people's lives and the social economy. Kenya Medical Research Institute (KEMRI), with the support from Japan for over the roughly half century since its establishment in 1979, has been developing facilities such as research departments and laboratories, and, as a result of supporting human resource development in the field of tropical infectious-disease research, has become a leading center of research on the control of such diseases in East Africa, conducting joint research with oversea institutes and providing training for medical personnel outside of Kenya. As KEMRI's response to the COVID-19 pandemic, the institute played a central role in PCR testing in Kenya, being commissioned by the Africa Centers for Disease Control and Prevention (Africa CDC) to carry out performance tests on testing kits that would then be used across Africa, demonstrating the instituteβs contributions to infectious disease control beyond borders.
1. Facility improvements/equipment procurement
Construction of research complexes, procurement and installation of equipment for research and testing, provision of emergency generators, etc.
2. Consulting services
Detailed design work, bidding assistance, construction/procurement supervision, training for the proper operation and maintenance of facilities and equipment (as the soft component).